U.S. Vessel Sealing Devices Market Size, Share, Regional Growth, 2026-2034

Market Overview

According to fortune business insights, The U.S. vessel sealing devices market was worth USD 699.7 million in 2022. The market is anticipated to grow at a CAGR of 7.1% during the forecast period. North America dominated the market as the report focuses on the U.S.The analysis shows that the increasing number of surgical procedures and a preferential shift toward minimally-invasive and robotic-assisted surgical procedures are resulting in the growing adoption of vessel sealing devices among surgeons. For example, according to an article published by the National Center for Biotechnology Information (NCBI), about 9.6 million inpatient surgeries were performed in the U.S. in 2018. This trend indicates a strong demand for vessel sealing devices.

Major Players Profiled in the Market Report:• Medtronic (Ireland)• Ethicon US, LLC. (U.S.)• Olympus Corporation (Japan)• B. Braun SE (Germany)• Intuitive Surgical (U.S.)• CONMED Corporation (U.S.)• OmniGuide Holdings, Inc. (U.S.)

SegmentsTechnological Advancements to Drive Electro-thermal Vessel Sealer Devices Segment GrowthBased on product, the market is segmented into electro-thermal vessel sealer devices, ultra-coagulation shears, and hybrid. The electro-thermal vessel sealer devices segment holds a larger share due to the increasing number of products being introduced by key players in the market. The efficiency, durability, and technological advancements of these vessel sealing devices are resulting in their higher adoption among surgeons.

High Adoption in Hospitals to Propel Instruments Segment DominanceBased on component, the market segments are generators, instruments, and accessories. The instruments segment dominated the market in 2022 owing to the increasing adoption of instruments in hospitals and ambulatory surgical centers, resulting in a growing focus of key players to receive approvals for these instruments in the market.

Rising Accident Cases to Drive General Surgery Segment GrowthBased on surgery type, the market is divided into general surgery and laparoscopic surgery. The general surgery segment accounted for a larger market share in 2022. Rising cases of road accidents and the preference for general surgeries for these patients are some factors contributing to the dominance of the segment.

Growing Prevalence of Heart Conditions to Propel Cardiothoracic SegmentBased on application, the market is segmented into urology, gynecology, cardiothoracic, gastroenterology, and others. The cardiothoracic segment dominated the market in 2022. The growing prevalence of cardiothoracic disorders, such as heart failure, is resulting in an increasing number of patient admissions in hospitals.

Increase in Surgical Procedures to Drive Hospital & ASCs Segment DominanceBased on end-user, the market is divided into hospital & ASCs, specialty clinics, and others. The hospitals & ASCs segment dominated in 2022 due to a higher number of ambulatory surgical procedures, expansion of the healthcare sector, and an increase in the number of hospitals & ASCs.

Source: https://www.fortunebusinessinsights.com/u-s-vessel-sealing-devices-market-108894

Report CoverageThe report offers:• Major growth drivers, restraining factors, and emerging trends for the market.• Details on the impact of COVID-19 on the market.• List of major industry players.• Key strategies adopted by the market players, such as technological advancements.• The latest industry developments include product launches, partnerships, mergers, and acquisitions.

Drivers & RestraintsRising Number of Surgeries to Augment the Demand for Vessel Sealing DevicesThe rising number of traumatic injuries, such as road accidents, and the rising patient population seeking treatment for disorders, including urological and gynecological, is aiding in the growing number of surgeries. Along with this, the growing awareness about advanced surgical instruments among surgeons and high healthcare expenditure is leading to the rising adoption of these devices. For instance, according to statistics from an article published by the National Center for Biotechnology Information (NCBI), it was reported that about 40.0 to 50.0 million surgeries are performed every year in the U.S.

However, the high price range associated with bipolar devices is likely to limit the product adoption among surgeons and impede the U.S. vessel sealing devices market growth. For instance, according to a 2023 article published by NCBI, the cost of a monopolar device is around USD 745.0, while a bipolar device is around USD 800.0.

U.S. Vessel Sealing Devices Market Trends:The U.S. vessel sealing devices market is experiencing robust growth, fueled by the increasing adoption of minimally invasive surgeries, which offer benefits such as less pain, reduced hospital stay, and faster patient recovery time. Today’s surgeons are increasingly drawn to devices that offer higher accuracy, smaller incisions, and less scarring. Additionally, key players are focusing on launching advanced vessel sealing devices to meet this demand. The rapid expansion of robotic-assisted surgeries and the rising number of overall surgical procedures are also key growth drivers.

Competitive LandscapeStrategic Approvals and Acquisitions to Strengthen Market Position of Key PlayersThe market features prominent players like Medtronic, Olympus Corporation, Ethicon, and B. Braun SE. These leading companies captured a prominent market share due to their strong presence, innovation, R&D activities, and robust product portfolios. Their proactive approach to receiving regulatory approvals and engaging in mergers and acquisitions continues to fuel the market’s momentum.

Key Industry Development• March 2022: CONMED Corporation granted U.S. FDA approval for its ElectroSurgical Cutting and Coagulation Device and Accessories to support the rising demand for novel surgical instruments among surgeons.• June 2021: Ethicon expanded its advanced bipolar energy portfolio with the launch of the Enseal X1 Curved Jaw Tissue Sealer to increase procedural efficiency.• December 2020: Olympus Corporation acquired Veran Medical Technologies, Inc., a provider of advanced medical devices, with an aim to strengthen its global position as a medical device company.